Tyra Biosciences, Inc. SEC filings TYRA
Tyra Biosciences, Inc. has 426 filings in SEC EDGAR's recent list, going back to May 28, 2021. Its latest annual report, Form ARS, was filed on Apr 17, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 4, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Sep 15, 2026 (other events). The company's fiscal year ends on December 31.
| Form | Description | Filed | Period |
|---|---|---|---|
| EFFECT | Filing | May 16, 2025 | — |
| CORRESP | Letter to the SEC | May 14, 2025 | — |
| UPLOAD | Letter from the SEC | May 12, 2025 | — |
| EFFECT | Filing | Apr 22, 2024 | — |
| CORRESP | Letter to the SEC | Apr 18, 2024 | — |
| UPLOAD | Letter from the SEC | Mar 22, 2024 | — |
| D | Filing | Feb 13, 2024 | — |
| EFFECT | Filing | Oct 13, 2022 | — |
| CORRESP | Letter to the SEC | Oct 11, 2022 | — |
| UPLOAD | Letter from the SEC | Oct 11, 2022 | — |
| EFFECT | Filing | Sep 14, 2021 | — |
| CERT | Filing | Sep 13, 2021 | — |
| 8-A12B | Filing | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Sep 10, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| CORRESP | Letter to the SEC | Aug 20, 2021 | — |
| UPLOAD | Letter from the SEC | Jul 13, 2021 | — |
| DRSLTR | Filing | Jul 2, 2021 | — |
| DRS/A | Filing | Jul 2, 2021 | — |
| UPLOAD | Letter from the SEC | Jun 25, 2021 | — |
| DRS | Filing | May 28, 2021 | — |
Showing 22 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.
New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.
Company profile
- Industry
- Pharmaceutical Preparations (SIC 2834)
- Listed as
- TYRA (Nasdaq)
- Fiscal year ends
- December 31
- Incorporated in
- DE
- Headquarters
- Carlsbad, CA
- SEC filer status
- , Emerging growth company
- SEC CIK
- 1863127
Other Pharmaceutical Preparations companies
- ELI LILLY & Co LLY
- Johnson & Johnson JNJ
- AbbVie Inc. ABBV
- Merck & Co., Inc. MRK
- Novartis AG NVS
- Astrazeneca PLC AZN
- Abbott Laboratories ABT
- Novo Nordisk A S NVO
Source: SEC EDGAR filings. This is company-reported data, not investment advice.